In this study we investigated the presence and anatomical location of atrial natriuretic factor (ANF) receptor subtypes in the rat central nervous system using in vitro autoradiographic and cross-linking techniques. 
A trial natriuretic factor (ANF) is a circulating / \ hormone and neuropeptide involved, among A. \ . other functions, in the regulation of blood pressure and fluid and electrolyte homeostasis. 1 ' 2 The biological effects of this peptide presumably are initiated by ANF binding to its specific receptors. To date, three types of plasma membrane ANF receptors have been defined by molecular cloning techniques: ANF-A, ANF-B, and ANF-C. 3 - 5 The ANF-A and ANF-B receptor subtypes contain both an ANF binding site and a region with guanylate cyclase activity within a single protein molecule 34 and exhibit an apparent molecular mass of 120-140 kDa. These two receptor subtypes impose stringent constraints on ligand structure for binding and stimulation of cyclic GMP. 6 The ANF-C receptor subtype is a non-guanylate cyclase-containing receptor, 5 existing on the cell membrane predominantly as a homodimer of 60-70 kDa subunits. 1^7 This receptor subtype binds native ANF as well as a range of truncated, ring-deleted and linear ANF analogues with high affinity. 6 One of the first synthetic ligands showing selectivity for the ANF-C receptor was C-ANF (des-[Gln ]-NH 2 ). 8 More recently, a number of linear peptides corresponding to various fragments of the ANF sequence have been shown to retain nanomolar affinities for ANF-C but not for ANF-A or ANF-B receptors, thus being able to discriminate between guanylate cyclase-containing and non-guanylate cyclase-containing ANF receptor subtypes. 6 In fact, linear peptides as short as seven to 10 amino acids in length, encompassing residues 109-113 of rat ANF, are endowed with selective ANF-C receptor binding abilities.
ANF-C receptor was demonstrated to be coupled to the adenylate cyclase/cyclic AMP system (through Gi proteins) 9 and to phosphoinositide turnover (also through G regulatory proteins). 10 In addition, other reports have suggested a possible indirect coupling of this receptor to the guanylate cyclase/cyclic GMP system.
11
- 13 Whether these mechanisms of signal transduction are interrelated is as yet unknown.
Binding and affinity cross-linking studies have shown that the ratio of guanylate cyclase-containing to guanylate cyclase-free ANF receptors varies extensively from tissue to tissue. 13 -14 In peripheral tissues, the ANF-C receptor usually constitutes the majority of total ANF binding sites. 615 However, only fragmentary information is available on this receptor in the central nervous system (CNS).
-

16
- 17 We therefore conducted in vitro autoradiographic and cross-linking studies to explore the presence and anatomical location of ANF-C receptors in the brain and related structures, as well as the relative proportion of ANF-C sites to all ANF specific binding sites in a given tissue.
Methods
Radioiodination ofAtrial Natnuretic Factor
Iodination of rat ANF- (Ser   99   -Tyr   126 ) (Bio-Mega Inc., Laval, Quebec, Canada) was performed by the lactoperoxidase method with 125 I-sodium. 18 Purification of the monoiodinated form of ANF was achieved by high-performance liquid chromatography. The specific activity of 1Z5 I-ANF was approximately 2,400 dpm/fmol (1,100 Ci/mmol).
In Vitro Autoradiography
The method of in vitro autoradiography has been described in detail elsewhere.
19
- 20 Briefly, adult Sprague-Dawley rats were killed by decapitation, and their brains were removed rapidly and frozen and sectioned in a cryostat. The cryostat tissue sections then were preincubated at room temperature for 10 minutes in 50 mM Tris-HCl buffer (pH 7.5) containing 0.5% bovine serum albumin and were incubated for 90 minutes in the same buffer supplemented with 100 pM 125 I-ANF and the appropriate concentrations of unlabeled ligands (see below), as well as 10" 6 I-ANF binding, a set of sections was incubated in the presence of 10~6 M angiotensin II, glucagon, or substance P. For competition analysis, the incubation buffer contained either unlabeled ANF, C-ANF, or ANF-(106-113)-NH 2 in concentrations ranging from 10~1 2 to 10~5 M. After incubation, the slides were washed (two times, 10 minutes each, 4°C) in 50 mM Tris-HCl (pH 7.5) containing 0.5% bovine serum albumin, were fixed (15 minutes) in 2% glutaraldehyde (pH 7.5, 4°C), were washed (5 minutes) in 0.1 M phosphate buffer (pH 7.5, 4°C) and in distilled water, and were dehydrated in alcohol and dried overnight at 60°C. Subsequently, the sections along with I standards were apposed to x-ray films for 2-3 days at room temperature.
Microdensitometry and
125
I Standards
Autoradiograms were analyzed with a computerized microdensitometer. 20 Optical density values were converted into disintegrations per minute per milligram of polymer standard and femtomoles per milligram of protein using two types of 6 to 50xl0~6 dpm), were mixed carefully by vortexing for 5 minutes, were frozen on dry ice, and were sectioned in a cryostat (20 /xm). The amount of radioactivity was measured in a gamma counter (Pharmacia LKB Biotechnology, Uppsala, Sweden), whereas the protein content per section was assessed by the method of Bradford. 21 To facilitate anatomical identification of brain structures on autoradiograms, the 125 I-ANF-labeled sections were stained with cresyl violet after autoradiography and subsequently were compared with their respective autoradiograms.
Analysis of Binding Data
Results from the binding distribution studies are presented as mean±SEM from two to five experiments ( 125 I-ANF binding displaced, expressed in femtomoles per milligram protein; Table 1 ) or as mean±SEM of nine to 16 readings from one representative experiment ( 125 I-ANF bound, given as disintegrations per minute per milligram polymer standard; Figure 1 ) (one animal per experiment). Statistical differences between means were analyzed by the Student's t test. Differences were considered significant atp<0.05. Competition binding curves (one to three separate experiments, one to three animals per experiment) were analyzed with the ALLFIT computer program (see Reference 22) , based on the four-parameter logistic equation, 22 to obtain estimates of the degree of displacement of bound 125 I-ANF by unlabeled ligands and to compute the unlabeled ligand concentration at which the maximum binding of labeled ligand is displaced by 50% ( Q )
Preparation of Membranes
The olfactory bulbs (OBs) of 10 Sprague-Dawley rats were dissected, cleaned from surrounding highly vascularized membranes, and homogenized with a hand homogenizer in a buffer containing 20 mM M phosphoramidon, and 10~7 M pepstatin A. The homogenate was centrifuged at l,000g for 10 minutes. The pellet was discarded, and the supernatant was centrifuged at 25,000g for 20 minutes. The resulting pellet was washed twice with the homogenization buffer and resuspended in 200 ul of a buffer containing 50 mM Tris-HCl, 250 mM sucrose, 0.1 M EDTA, and 1 mM MgCl 2 (pH 7.4). Aliquots were taken for protein determination 21 and for the binding assay. All membranes were kept frozen at -70°C until they were used.
Affinity Cross-linking and Sodium Dodecyl Sulfate-Pofyacrylamide Gel Electrophoresis
Fifty-microgram protein aliquots of the OB membranes were incubated for 60 minutes at room temperature in a binding buffer containing 55 pM 125 I-ANF and increasing concentrations (0-10 M) of unlabeled ANF, C-ANF, or ANF-(106-113)-NH 2 . Subsequently, the membranes were treated in 0.5 mM of disuccimidyl suberate dissolved in dimethylsulfoxide for 15 minutes at room temperature. The reaction was stopped by addition of ammonium acetate to a final concentration of 50 mM. Samples then were denatured with 2.5% sodium dodecyl sulfate containing 2% ^-mercaptoethanol, boiled for 5 minutes, and resolved on 8% polyacrylamide gel 23 along with the molecular mass standards (Pharmacia LKB). The gel was stained in Coomassie blue R-250, dried, and exposed for 5-14 days to Kodak X-Omat RP film (Eastman Kodak Co., San Diego, Calif.) at -70°C. The relative density of the bands on the resulting autoradiograms was assessed by densitometry.
20
Results
Distribution Binding Studies
As shown in Table 1 and Figure 1 , specific ANF binding sites were widely, but distinctly, distributed in the rat CNS. The highest concentration of ANF binding sites occurred in the pia-arachnoid (PA), external plexiform layer of the OB, area postrema (AP), choroid plexus (ChP), interpeduncular nucleus, habenular nucleus, and subfornical organ (SFO).
C-ANF at a concentration of 10~6 M had a smaller but significant effect on (Table IV Unrelated peptides (at a concentration of 10 M) generally did not affect 125 I-ANF binding (Figure 1 , panels E, J, and O); however, in a few experiments a nonspecific displacement occurred in some tissues (e.g., the median preoptic nucleus, SFO).
PEPTIDE CONCENTRATION (-log M] FIGURE 2. Competition of atrial natriuretic factor (ANF) (•-•), C-ANF (O-o), and ANF-(106-U3)-NH
Competition Binding Studies
To investigate the characteristics of ANF, C-ANF, and ANF-(Phe In contrast, C-ANF competed with an IQo in nanomolar concentrations only in the ChP and PA (IC50, 2.4 and 16.1 nM, respectively) and was able to displace approximately 70% of I-ANF binding to these structures (Figures 2A and 2B) . In other tissues examined, C-ANF displaced c for each peptide considered) in comparison to C-ANF, which renders the peptide more suitable for discriminating between the guanylate cyclasecontaining and non-guanylate cyclase-containing receptor subtypes, as well as for assessing their relative proportions in target tissues.
Affinity Cross-linking Studies
To ascertain the molecular mass of the ANF receptor present in the brain and to identify the receptor from which C-ANF displaced 9-11) .
In addition, on the top of the gel, between the 170 and 212 kDa molecular size markers, a very prominent band was observed whose intensity also was decreased on addition of increasing concentrations of unlabeled ANF. That band, however, seemed to represent merely an unresolved portion of the receptors, because it did not appear on autoradiograms (exposed to equivalent intensity of 120 kDa band) when a lesser quantity of the cross-linked membranes was applied to the gel (data not shown). Finally, a faint band migrating with an apparent molecular mass of 67 kDa also was identified but was considered to be nonspecific, because labeling of this site was not diminished by the addition of increasing concentrations of the unlabeled competitive peptides.
Discussion
It already has been demonstrated 2425 (and reconfirmed in this study) that ANF binding sites are present in the brain. In the current examination, we investigated the presence and anatomical location of ANF-C receptors in the rat CNS using in vitro autoradiographic and affinity cross-linking techniques. The fact that C-ANF, a selective ligand for ANF-C receptors, 8 displaced (in our distribution experiments) 125 I-ANF binding from a number of brain structures at a concentration of 10~6 M led us to think that the ANF-C subtype could be expressed in the brain. To further investigate this possibility, we performed competition binding experiments on a number of CNS structures that were large enough to provide a sufficient number of sections for full displacement analysis and that possessed a relatively high concentration of ANF receptors. In addition, we used another ligand selective for the ANF-C receptor, namely, ANF-(106-113)-NH 2 , whose amino acid sequence encompasses the structural feature responsible for recognition of the ANF-C receptor. 6 This peptide retains a high affinity (K b 2-15 nM) for the ANF-C receptors in cultured vascular smooth muscle cells and isolated perfused kidney 26 and inhibits adenylate cyclase activity and cyclic AMP levels in vascular smooth muscle cells from rat aorta with a potency similar to that of C-ANF and ANF. 9 Analysis of the competition curves revealed, however, that C-ANF inhibition of 125 I-ANF binding in CNS structures, with the exception of the PA and ChP, had the characteristics of interaction with the ANF-A or ANF-B rather than the ANF-C receptor (ICJO>1 /iM). Affinity cross-linking studies with the OB membranes provided compelling evidence that the C-ANF-induced inhibition of 125 I-ANF binding in the OB, observed in the autoradiographic studies, was indeed due to its interaction (at high concentrations only) at the ANF-A or the ANF-B sites and not due to its effect on the ANF-C receptor. However, the linear ANF analogue ANF-(106-113)-NH 2 has been shown to possess a better selectivity factor than C-ANF, thus making this ligand more suitable for discriminating between guanylate cyclase-containing and guanylate cyclase-free ANF receptor subtypes, as well as for assessing their ratio in target structures. The high selectivity for the ANF-C receptor displayed by the ANF-(106-113)-NH 2 analogue was particularly useful in those CNS structures in which neither cross-linking nor full competition studies I-ANF binding in the OB detected in the distribution studies may not represent the displacement from ANF-C receptors, because the existence of a specific band that would correspond to the low molecular weight receptor has not been detected by our and other 27 cross-linking studies. Similarly, the effect of ANF-(106-113)-NH 2 on 125 I-ANF binding in the AP has not been consistent in the two experiments performed, and hence not much credibility can be given to this finding.
Our demonstration of the presence of ANF-C receptors in the PA and ChP is in agreement with previous investigations.
1617
- 28 The failure to detect receptors of this kind elsewhere in the brain also is consistent with earlier autoradiographic studies. 16 However, those investigations did not detect ANF-C sites in any CNS structures examined, with the exception of the PA. Interestingly, binding studies performed on cultured glial cell membranes from the rat diencephalon 29 and neocortex 30 (note that glial cells constitute up to 50% of the total mass of the brain) showed a 95% displacement of 125 I-ANF binding by C-ANF, with an IQo in subnanomolar concentrations. 2930 Similarly, affinity cross-Unking studies, carried out on rat cultured glial cell membranes, demonstrated the presence of bands corresponding to the low (and high) molecular weight ANF receptors. 29 These findings, however, must be interpreted very cautiously, because it has been shown that expression of several receptors (including the ANF receptor 31 ) can be dramatically influenced by cell culture conditions or by the early developmental stage of cultured cells. In this respect, autoradiographic studies performed on intact animal tissues are superior to those carried out on cultured cells, because they more closely resemble the in vivo conditions.
The abundance of ANF-C receptors in highly vascularized tissues located outside the blood-brain barrier, such as the PA and ChP, is consistent with the proposed functional role of ANF-C sites in the clearance and metabolism of circulating ANF. 8 The absence of ANF-C sites in the brain beyond the bloodbrain barrier would suggest that these receptors do not have a similar role in the inactivation of brainreleased ANF. However, the failure to identify ANF-C receptors by in vitro autoradiographic techniques in a majority of CNS structures does not necessarily indicate a lack Qf expression of this receptor in those tissues. This may be due to occupancy of ANF-C subtype with endogenous ANF before labeling of the receptor with iodinated ligand, or to the sensitivity limit of the method. The first possibility, however plausible, is rather unlikely, because before exposure to radioligand, the tissue sections were preincubated at room temperature in a peptidase inhibitor-free buffer, and during this step the endogenous peptides would be expected to dissociate from their receptors. With respect to the second possibility, although the in vitro autoradiographic technique provides several-fold greater sensitivity and better anatomical resolution than conventional membrane binding studies, 32 receptors present at very low concentrations still may remain undetectable. In fact, assuming that the ANF-C receptor is coupled to adenylate cyclase through Gi proteins, 9 its presence has been shown in the rat striatum and anterior pituitary by the demonstration of inhibition of both the adenylate cyclase activity and cyclic AMP levels produced by C-ANF, ANF-(106-113)-NH 2 , and other truncated and linear ANF analogues. 9 Whether the receptors reside in the vascular bed of the brain or beyond the blood-brain barrier was not shown by these studies. Other highly sensitive techniques that allow simultaneous morphological identification of ANF receptor-bearing cells are needed to address this question and to resolve present discrepancies.
